The Heroin Epidemic in America: Latest Statistics

The heroin epidemic in America did not appear overnight. It grew slowly, quietly, in medicine cabinets and doctors’ offices before it spilled onto street corners and into emergency rooms across the country. What began as a prescription painkiller crisis in the 1990s evolved into one of the most destructive public health disasters in modern U.S. history — and heroin sat at the center of it for over a decade.

Today, the landscape is shifting. Heroin use and heroin-related deaths have declined significantly compared to their 2016 peak, when nearly 15,500 Americans died from heroin overdoses in a single year. But that decline tells only part of the story. In many ways, the drug that replaced heroin — illicitly manufactured fentanyl — is deadlier, cheaper, and more widespread. For millions of Americans, the path to fentanyl started with heroin. And for many, it started long before that with a legal prescription.

This article unpacks the latest numbers behind the heroin epidemic in America, looks at who has been most affected, explains how the crisis evolved through distinct waves, and covers what treatments and policy responses are actually working. Whether you are a researcher, a concerned family member, a healthcare provider, or just someone trying to understand what is happening in communities across the country, this guide gives you the full picture — with data to back every claim.

The Heroin Epidemic in America: How It Started

The Three Waves of the Opioid Crisis

To understand the heroin epidemic in America, you have to understand it as the second chapter of a larger story — the opioid epidemic. The CDC describes this crisis in three distinct waves, each one more dangerous than the last.

Wave 1 — Prescription Opioids (Starting Around 1999)

The first wave started when pharmaceutical companies aggressively marketed opioid painkillers like OxyContin, and doctors across the country prescribed them at unprecedented rates. The national opioid prescription rate peaked in 2012, with over 255 million prescriptions written — roughly 81.3 prescriptions for every 100 people in the country. Overdose deaths involving prescription opioids rose from 3,442 in 1999 to a peak of 17,029 in 2017.

Wave 2 — Heroin (Starting Around 2010)

As state and federal regulators cracked down on prescription opioids, many people who were already physically dependent turned to heroin. The reason was simple and tragic: heroin was cheaper, easier to get, and produced a similar high. Many individuals, unintentionally dependent on these medications, turned to heroin when prescriptions became difficult to obtain, since heroin was often cheaper and more accessible than prescription opioids. Heroin overdose deaths climbed from 3,036 in 2010 to a peak of 15,469 in 2016.

Wave 3 — Synthetic Opioids (Starting Around 2013)

Illicitly manufactured fentanyl and its analogs began flooding the drug supply. Fentanyl is approximately 50 times more potent than heroin and 100 times more potent than morphine. Drug dealers started mixing it into heroin to cut costs and boost potency — often without the buyer knowing. This made an already dangerous drug into a potential death sentence. The rise in opioid overdose deaths is shown in three waves, with a slight decrease from 2022 to 2023, and from 1999 to 2023, approximately 806,000 people died from an opioid overdose.

Current Heroin Epidemic Statistics in America (2023–2025)

How Many People Use Heroin in the United States?

Almost 6.25 million Americans will use heroin at least once in their lifetime, and annually over 902,000 Americans use heroin regularly. Among people aged 12 or older in 2021, about 1.1 million people reported using heroin in the past 12 months, and an estimated 1.0 million people had a heroin use disorder in the past 12 months.

One of the most important data points for understanding how the heroin epidemic spread is the connection to prescription opioids. Almost 80% of people who currently use heroin first misused prescription opioids. That statistic tells you almost everything you need to know about how this crisis was built.

Heroin Overdose Deaths: A Closer Look

Drug overdose deaths involving heroin rose from 3,036 in 2010 to 15,469 in 2016. Since 2016, the number of deaths has trended down with 3,984 reported deaths in 2023. That is a significant drop — more than 75% from the peak. But it does not mean heroin’s influence on the overdose crisis has disappeared. It means fentanyl has largely taken over.

While the overall number of heroin-involved overdose deaths decreased, the proportion of these deaths co-involving heroin and illicitly manufactured fentanyl (IMF) increased to 80% in 2022 and remained high through 2023.

In 2023, nearly 4,000 overdose deaths involved heroin. This is about 4% of all drug overdose deaths and 5% of all opioid overdose deaths in 2023. The rate of overdose deaths involving heroin decreased approximately 33% from 2022 to 2023.

Overall Drug Overdose Deaths Are Declining — But the Crisis Is Not Over

In 2024, 79,384 drug overdose deaths occurred, resulting in an age-adjusted rate of 23.1 deaths per 100,000 standard population. The U.S. drug overdose death rate increased from 2014 (14.7) to 2022 (32.6) and then decreased through 2024. The largest decrease, 26.2%, occurred between 2023 and 2024, from 31.3 to 23.1 deaths per 100,000.

New preliminary data predicts 70,231 drug overdose deaths for the 12 months ending in November 2025, which is a 15.9% decline in U.S. overdose deaths compared to the previous year.

These numbers represent real progress. But with over 70,000 overdose deaths still projected annually, calling the crisis resolved would be dangerously premature.

Who Is Most Affected by the Heroin Epidemic?

Demographics of Heroin Use and Overdose

The heroin epidemic in America has not hit all communities equally. Understanding who bears the greatest burden is critical to targeting resources where they are needed most.

Age

• Americans between the ages of 18 and 25 are most likely to use addictive drugs, including heroin.
• From 2023 to 2024, rates of drug overdose deaths declined for all age groups, with the largest decreases occurring for younger age groups.

Gender

• Of patients admitted to state-regulated programs for heroin treatment between 2000 and 2017, 66.4% were male.
• The overdose death rate decrease from 2023 to 2024 was 27.3% for males (from 44.3 to 32.2 per 100,000) and 23.0% for females (from 18.3 to 14.1). For both men and women, this decrease was the single largest annual decrease observed across the 10-year period.

Race and Ethnicity The overdose crisis has increasingly fallen harder on communities of color, particularly Black and Indigenous Americans. Demographic disparities remain one of the most concerning issues in opioid mortality, with Black Americans experiencing 35.0 deaths per 100,000, Indigenous Americans 28.5 deaths per 100,000, White Americans 21.9 deaths per 100,000, and Asian Americans 3.1 deaths per 100,000.

From 2023 to 2024, rates declined for each race and Hispanic-origin group, with the largest decreases occurring for Black non-Hispanic people. That is encouraging, but these communities still face disproportionately high overdose rates and deserve focused policy attention.

Geography Washington D.C. and southern states — including West Virginia, Tennessee, Kentucky, South Carolina, and Louisiana — continued to have the highest per capita scores and appear to be most detrimentally affected by addiction, particularly relating to the opioid epidemic.

The Fentanyl Connection: How Heroin Became Even More Dangerous

Why Fentanyl Changed Everything

If the heroin epidemic was a wildfire, fentanyl poured gasoline on it. Understanding the relationship between heroin and fentanyl is essential to understanding current overdose statistics in America.

Fentanyl first crept into the heroin supply as a cost-cutting adulterant. Because it is so much more potent, dealers could use smaller amounts to produce a stronger effect, maximizing profit margins. The problem is that users had no way of knowing how much fentanyl was in what they were buying. A batch that was 90% heroin one week might be 90% fentanyl the next — and the dosing difference between the two is potentially fatal.

According to the Drug Enforcement Administration (DEA), fentanyl is estimated to be 100 times more potent than morphine and 50 times as potent as heroin. The DEA estimates that just 2mg of fentanyl — approximately the size of the tip of a pencil — is enough to kill the average healthy adult, and that over 376 million lethal doses of fentanyl were confiscated in 2023 alone.

Fentanyl was identified in 66% of heroin samples analyzed in DEA regional laboratories in 2024, along with typical heroin adulterants.

This contamination problem is why public health experts increasingly talk about the opioid crisis in terms of the drug supply rather than individual substances. The person who thinks they are using heroin may actually be using fentanyl. That distinction can mean the difference between life and death.

The Shift From Heroin to Synthetic Opioids

While heroin is still present in some areas, many people with prior heroin addiction have transitioned to fentanyl or sought heroin addiction help through treatment. This shift underscores the importance of continued access to effective opioid addiction treatment.

Overdose deaths involving any type of opioid decreased from an estimated 83,140 in 2023 to 54,743 in 2024. The overall trend is moving in the right direction, but the drug supply remains volatile and unpredictable.

The Economic Cost of the Heroin Epidemic in America

The heroin epidemic and the broader opioid crisis carry a staggering financial price tag — one that falls on taxpayers, employers, healthcare systems, and families alike.

• The federal budget for drug control in 2024 was nearly $45 billion.
• In 2024, the National Drug Control Budget requested $44.5 billion across agencies focused on expanding efforts to reverse opioid overdoses, disrupt the drug supply chain, and provide support for prevention, treatment, and recovery — including $21.8 billion to expand access to treatment for substance use disorder and overdose prevention.

Beyond direct healthcare and law enforcement costs, the epidemic drains the economy through lost workplace productivity, increased foster care placements, emergency room utilization, and long-term disability claims. Some economic analyses have placed the total annual cost of the opioid epidemic — which includes heroin — at well over $500 billion annually when all downstream effects are counted.

Treatment for Heroin Addiction: What Works

Medications for Opioid Use Disorder (MOUD)

The most evidence-backed approach to treating heroin addiction involves medications for opioid use disorder, commonly known as MOUD. These include:

• Methadone — a long-acting opioid agonist that reduces cravings and withdrawal symptoms. It has been used for decades and is highly effective when properly administered.
• Buprenorphine (Suboxone) — a partial opioid agonist that blocks cravings and reduces the effects of other opioids. It can be prescribed in outpatient settings, making it far more accessible than methadone.
• Naltrexone (Vivitrol) — an opioid antagonist that completely blocks opioid effects. Available as a monthly injection, it works best for patients who are already detoxed.

These medications are not substitutes for addiction — they are treatments, the same way insulin is a treatment for diabetes. The data consistently shows they reduce overdose deaths, decrease criminal activity, improve employment outcomes, and increase treatment retention.

In 2023, an estimated 54.2 million Americans aged 12 or older needed substance use disorder treatment in the past year, but only 12.8 million people with a substance use disorder in the past year received treatment. That gap — between those who need help and those who get it — is one of the defining challenges of the heroin epidemic in America.

Harm Reduction Strategies

Harm reduction approaches acknowledge that not everyone is ready or able to stop using drugs immediately, and that keeping people alive is a prerequisite to recovery. Key harm reduction tools include:

1. Naloxone (Narcan) — an opioid overdose reversal medication available over the counter in most states. When administered quickly, it can reverse a heroin or fentanyl overdose within minutes.
2. Needle exchange programs — also called syringe service programs (SSPs), these reduce transmission of HIV and hepatitis C among people who inject drugs and serve as an entry point to treatment.
3. Fentanyl test strips — low-cost tools that allow users to test their drugs for fentanyl contamination before use.
4. Safe consumption sites — still limited in the U.S. but growing in conversation, these supervised locations allow people to use drugs under medical supervision, with trained staff available to reverse overdoses.

Prevention: Addressing the Root Causes

Prescription Drug Monitoring and Overprescribing

Since overprescribing was the spark that ignited the heroin epidemic in America, reducing inappropriate prescribing remains a core prevention strategy. Beginning in the early 2010s, states that began to enhance their prescription drug monitoring programs (PDMPs) saw drastic results. PDMPs allow healthcare providers and pharmacies to track opioid prescriptions in real time, identifying patterns of misuse or “doctor shopping.”

The results have been measurable. Drug overdose deaths involving prescription opioids rose from 3,442 in 1999 to 17,029 in 2017, but from 2017 to 2023, there was an overall decline to 13,026. Tighter prescribing guidelines and improved monitoring played a significant role in that decline.

Community-Based Prevention

Prevention works best when it is rooted in communities, not just policy documents. The CDC’s Drug-Free Communities (DFC) Program supports community coalitions to prevent and reduce youth substance use. Schools, faith communities, and local organizations all play a role in addressing the heroin epidemic at the ground level.

Early education about the risks of opioid misuse — including the gateway from prescription drugs to heroin and fentanyl — is one of the most cost-effective prevention tools available.

The Road Ahead: Is the Heroin Epidemic Ending?

Signs of Progress

The data from the past two years is cautiously encouraging. The largest single-year decrease in the drug overdose death rate over the past decade — 26.2% — occurred between 2023 and 2024. Heroin-specific deaths have fallen by more than 75% from their 2016 peak. Access to naloxone has expanded dramatically. More treatment providers are offering buprenorphine. Fentanyl test strips are increasingly available.

These are not small wins. They represent real lives saved.

Reasons for Continued Vigilance

But experts are careful not to declare victory. The drug supply is still saturated with fentanyl and increasingly contaminated with xylazine (a veterinary sedative known as “tranq”), which does not respond to naloxone and causes severe wounds at injection sites. Stimulant-involved overdoses involving methamphetamine and cocaine are still rising. And the treatment gap remains enormous.

As of 2023, 47.7 million Americans aged 12 and older were current illegal drug users, and 16.8% of Americans 12 and over used drugs in the last month. The infrastructure to serve this population — treatment centers, trained providers, recovery housing — still falls far short of the need.

The heroin epidemic in America is not over. It has evolved. And the response needs to evolve with it.

Conclusion

The heroin epidemic in America is one of the most complex and costly public health crises in U.S. history, driven by decades of overprescribing, inadequate treatment access, and a volatile illicit drug supply increasingly dominated by fentanyl. From 1999 to 2023, approximately 806,000 Americans died from opioid overdoses, with heroin-related deaths peaking at nearly 15,500 in 2016 before declining by roughly 74% by 2023 — a shift driven less by reduced drug use and more by fentanyl displacing heroin in the drug supply. Today, roughly 902,000 Americans use heroin regularly, nearly 80% of whom began with prescription opioids, and the fentanyl contamination crisis means that heroin users are more likely than ever to encounter a lethal dose without knowing it.

The good news is that overdose deaths are declining — 2024 saw the largest single-year drop in over a decade — and proven treatments like buprenorphine and methadone, combined with expanded naloxone access and harm reduction strategies, are saving lives. But with over 70,000 overdose deaths still projected for 2025 and millions of Americans still unable to access treatment, this epidemic demands continued investment, compassionate policy, and a clear-eyed refusal to declare the problem solved.